O
CTMX icon

OrbiMed’s CytomX Therapeutics CTMX Stock Holding History

OrbiMed’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,525,650
Closed -$15M – 117
2025
Q4 		$15M Sell
3,525,650
-4,935,850
-58% -$18.8M 0.31% 69
2025
Q3 		$27M Hold
8,461,500
– – 0.65% 45
2025
Q2 		$19.2M Buy
+8,461,500
New +$13.6M 0.48% 42
2024
Q2 		– Sell
-3,544,578
Closed -$7.73M – 120
2024
Q1 		$7.73M Buy
+3,544,578
New +$6.54M 0.14% 90
2022
Q3 		– Sell
-2,124,975
Closed -$3.89K – 135
2022
Q2 		$3.89K Hold
2,124,975
– – 0.07% 119
2022
Q1 		$5.67M Sell
2,124,975
-1,089,534
-34% -$4.18M 0.09% 118
2021
Q4 		$13.9M Buy
3,214,509
+1,392,641
+76% +$8.16M 0.18% 104
2021
Q3 		$9.27M Buy
1,821,868
+308,700
+20% +$1.65M 0.1% 131
2021
Q2 		$9.58M Buy
+1,513,168
New +$11.8M 0.1% 127

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return